Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is the difference between apixaban and apixaban accord?Combivent inhaler hfc 152a patents?When is the expected fda decision date for apotex's ruxolitinib resubmission?Dabrafenib mesylate when the patent is expiring in india?Drug patent watch trametinib?
See the DrugPatentWatch profile for Bicalutamide
What’s Bicalutamide? Bicalutamide is a non‑steroidal anti‑androgen that blocks androgen receptors in prostate cells. By preventing testosterone from binding, it slows the growth of androgen‑sensitive tissues. Which patients get it? The drug is mainly used to treat prostate cancer in men, especially in the early or metastatic stages. It is sometimes prescribed for hormone‑sensitive breast cancer in women, but that use is less common and typically part of clinical studies. How do doctors dose it? In men, the standard dose is 50 mg once daily. In breast‑cancer protocols, doses vary and may be combined with other hormonal agents. The medication is taken orally and can be started immediately once a prescription is in place. What advantages does it have over other anti‑androgens? Bicalutamide has a better side‑effect profile than earlier agents like flutamide. It rarely causes liver toxicity, and its oral form is convenient for long‑term therapy. Side‑effects that patients often ask about Common complaints include hot flashes, nausea, and breast tenderness. Rarely, patients may experience liver enzyme elevations or gynecomastia. Most side‑effects resolve with dose adjustment or supportive care. When do patients see a response? Blood‑testosterone suppression is rapid, but noticeable changes in tumor markers or imaging typically appear after several weeks of continuous therapy. Can it be combined with other treatments? Yes. It is frequently paired with luteinizing‑hormone‑releasing hormone (LHRH) agonists or antagonists to intensify androgen suppression. In metastatic settings, chemotherapy may also be added. Is it approved for use in women? The U.S. Food and Drug Administration approves bicalutamide for men with prostate cancer. Its use in women is not officially approved in the U.S., though it is prescribed in some countries and studied in trials for breast cancer. Where can it be bought, and what’s the cost? In the U.S., bicalutamide is sold under brand names such as Casodex. Prices vary by pharmacy and insurance coverage; generic versions can reduce costs. Internationally, availability differs by country. What should patients do if they miss a dose? If a dose is forgotten, take it as soon as remembered unless the next scheduled dose is close. Do not double up to make up for a missed dose.
Other Questions About Bicalutamide :